CY1112102T1 - Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1 - Google Patents
Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1Info
- Publication number
- CY1112102T1 CY1112102T1 CY20111101174T CY111101174T CY1112102T1 CY 1112102 T1 CY1112102 T1 CY 1112102T1 CY 20111101174 T CY20111101174 T CY 20111101174T CY 111101174 T CY111101174 T CY 111101174T CY 1112102 T1 CY1112102 T1 CY 1112102T1
- Authority
- CY
- Cyprus
- Prior art keywords
- plk1
- pyramidodiazepine
- suspensions
- substituted
- formula
- Prior art date
Links
- 102100031463 Serine/threonine-protein kinase PLK1 Human genes 0.000 title abstract 2
- 108010056274 polo-like kinase 1 Proteins 0.000 title abstract 2
- 239000000725 suspension Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91935807P | 2007-03-22 | 2007-03-22 | |
| EP08717594A EP2139892B1 (en) | 2007-03-22 | 2008-03-11 | Substituted pyrimidodiazepines useful as plk1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1112102T1 true CY1112102T1 (el) | 2015-11-04 |
Family
ID=39415299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111101174T CY1112102T1 (el) | 2007-03-22 | 2011-11-30 | Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7517873B2 (enExample) |
| EP (1) | EP2139892B1 (enExample) |
| JP (1) | JP5087640B2 (enExample) |
| KR (1) | KR101157848B1 (enExample) |
| CN (2) | CN102746175B (enExample) |
| AR (1) | AR065794A1 (enExample) |
| AT (1) | ATE524472T1 (enExample) |
| AU (1) | AU2008228303B2 (enExample) |
| BR (1) | BRPI0809088A2 (enExample) |
| CA (1) | CA2680757A1 (enExample) |
| CL (1) | CL2008000785A1 (enExample) |
| CY (1) | CY1112102T1 (enExample) |
| DK (1) | DK2139892T3 (enExample) |
| ES (1) | ES2371832T3 (enExample) |
| HR (1) | HRP20110807T1 (enExample) |
| IL (1) | IL200617A (enExample) |
| MX (1) | MX2009010034A (enExample) |
| PE (1) | PE20120495A1 (enExample) |
| PL (1) | PL2139892T3 (enExample) |
| PT (1) | PT2139892E (enExample) |
| SI (1) | SI2139892T1 (enExample) |
| TW (1) | TWI363629B (enExample) |
| WO (1) | WO2008113711A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2695753A1 (en) * | 2007-08-15 | 2009-02-19 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinases inhibitors |
| US20110201818A1 (en) * | 2007-09-25 | 2011-08-18 | Takeda Pharmaceutical Company Limited | Polo-like kinase inhibitors |
| US8563542B2 (en) | 2007-09-28 | 2013-10-22 | Cyclacel Limited | Pyrimidine derivatives as protein kinase inhibitors |
| WO2009067547A1 (en) * | 2007-11-19 | 2009-05-28 | Takeda Pharmaceutical Company Limited | Polo-like kinase inhibitors |
| TWI490214B (zh) | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| EP2303889A1 (en) | 2008-06-18 | 2011-04-06 | F. Hoffmann-La Roche AG | Halo-substituted pyrimidodiazepines as plkl inhibitors |
| AU2009333559B2 (en) | 2008-12-09 | 2015-03-12 | Gilead Sciences, Inc. | Modulators of toll-like receptors |
| CA2748181C (en) | 2009-01-06 | 2019-07-16 | Nathanael S. Gray | Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| DK2442809T3 (en) | 2009-06-17 | 2016-12-19 | Vertex Pharma | Inhibitors of the replication of influenza virus |
| ES2661850T3 (es) | 2009-09-14 | 2018-04-04 | Gilead Sciences, Inc. | Moduladores de receptores del tipo toll |
| AU2011343642A1 (en) | 2010-12-16 | 2013-05-02 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| EP3670515B1 (en) | 2013-03-15 | 2024-03-06 | Dana-Farber Cancer Institute, Inc. | Pyrimido-diazepinone compounds and methods of treating disorders |
| WO2015013635A2 (en) | 2013-07-25 | 2015-01-29 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcription factors and uses thereof |
| TWI652014B (zh) * | 2013-09-13 | 2019-03-01 | 美商艾佛艾姆希公司 | 雜環取代之雙環唑殺蟲劑 |
| RS57541B1 (sr) | 2013-11-13 | 2018-10-31 | Vertex Pharma | Postupci za pripremu inhibitora replikacije virusa gripa |
| EP3068776B1 (en) | 2013-11-13 | 2019-05-29 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| WO2015117087A1 (en) | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
| EP3099677A4 (en) | 2014-01-31 | 2017-07-26 | Dana-Farber Cancer Institute, Inc. | Diaminopyrimidine benzenesulfone derivatives and uses thereof |
| TWI733652B (zh) | 2014-07-11 | 2021-07-21 | 美商基利科學股份有限公司 | 用於治療ＨＩＶ之ｔｏｌｌ樣受體調節劑 |
| EP3177626A4 (en) | 2014-08-08 | 2017-12-27 | Dana Farber Cancer Institute, Inc. | Diazepane derivatives and uses thereof |
| US9573952B2 (en) | 2014-09-16 | 2017-02-21 | Gilead Sciences, Inc. | Methods of preparing toll-like receptor modulators |
| JP2017526730A (ja) | 2014-09-16 | 2017-09-14 | ギリアード サイエンシーズ， インコーポレイテッド | Ｔｏｌｌ様受容体モジュレーターの固体形態 |
| JP6704416B2 (ja) | 2015-05-13 | 2020-06-03 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | インフルエンザウイルスの複製の阻害剤を調製する方法 |
| MA42422A (fr) | 2015-05-13 | 2018-05-23 | Vertex Pharma | Inhibiteurs de la réplication des virus de la grippe |
| EP3307728A4 (en) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS |
| PE20181287A1 (es) | 2015-09-11 | 2018-08-07 | Dana Farber Cancer Inst Inc | Ciano tienotriazolpirazinas y usos de las mismas |
| UA123946C2 (uk) | 2015-09-11 | 2021-06-30 | Дана-Фарбер Кенсер Інстітьют, Інк. | Ацетамідтієнотриазолодіазепіни й шляхи їх застосування |
| CA3003288A1 (en) | 2015-11-25 | 2017-06-01 | Dana-Farber Cancer Institute, Inc. | Bivalent bromodomain inhibitors and uses thereof |
| US11155556B2 (en) * | 2016-04-07 | 2021-10-26 | Dana-Farber Cancer Institute, Inc. | Pyrimido-diazepinone kinase scaffold compounds and methods for treating PI3K-mediated disorders |
| KR20220011685A (ko) | 2019-05-22 | 2022-01-28 | 길리애드 사이언시즈, 인코포레이티드 | Tlr7 조절 화합물과 hiv 백신의 조합 |
| EP4034132B1 (en) | 2019-09-27 | 2026-02-25 | Dana-Farber Cancer Institute, Inc. | Erk5 degraders as therapeutics in cancer and inflammatory diseases |
| KR20210122164A (ko) * | 2020-03-27 | 2021-10-08 | (주) 업테라 | Plk1의 선택적 분해를 유도하는 벤즈이미다졸 티오펜 유도체 화합물 |
| WO2022145989A1 (ko) * | 2020-12-31 | 2022-07-07 | (주) 업테라 | 선택적 plk1 억제제로서의 피리미도디아제핀 유도체 |
| KR102604801B1 (ko) * | 2021-08-10 | 2023-11-22 | (주) 업테라 | 신규 plk1 분해 유도 화합물 |
| GB202313514D0 (en) | 2023-09-05 | 2023-10-18 | Cambridge Entpr Ltd | Treatment of inflammatory diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001019828A2 (en) * | 1999-09-17 | 2001-03-22 | Basf Aktiengesellschaft | Kinase inhibitors as therapeutic agents |
| EA007062B1 (ru) | 2001-09-04 | 2006-06-30 | Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг | Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств |
| AU2007215221C1 (en) * | 2006-02-14 | 2013-05-30 | Vertex Pharmaceuticals Incorporated | Dihydrodiazepines useful as inhibitors of protein kinases |
| TW200808325A (en) * | 2006-07-06 | 2008-02-16 | Astrazeneca Ab | Novel compounds |
-
2008
- 2008-03-11 JP JP2009553997A patent/JP5087640B2/ja not_active Expired - Fee Related
- 2008-03-11 ES ES08717594T patent/ES2371832T3/es active Active
- 2008-03-11 DK DK08717594.9T patent/DK2139892T3/da active
- 2008-03-11 AU AU2008228303A patent/AU2008228303B2/en not_active Ceased
- 2008-03-11 PT PT08717594T patent/PT2139892E/pt unknown
- 2008-03-11 EP EP08717594A patent/EP2139892B1/en not_active Not-in-force
- 2008-03-11 BR BRPI0809088-2A patent/BRPI0809088A2/pt not_active IP Right Cessation
- 2008-03-11 PL PL08717594T patent/PL2139892T3/pl unknown
- 2008-03-11 KR KR1020097019761A patent/KR101157848B1/ko not_active Expired - Fee Related
- 2008-03-11 CA CA002680757A patent/CA2680757A1/en not_active Abandoned
- 2008-03-11 CN CN201210030872.3A patent/CN102746175B/zh not_active Expired - Fee Related
- 2008-03-11 SI SI200830445T patent/SI2139892T1/sl unknown
- 2008-03-11 MX MX2009010034A patent/MX2009010034A/es active IP Right Grant
- 2008-03-11 HR HR20110807T patent/HRP20110807T1/hr unknown
- 2008-03-11 AT AT08717594T patent/ATE524472T1/de active
- 2008-03-11 CN CN2008800088890A patent/CN101636399B/zh not_active Expired - Fee Related
- 2008-03-11 WO PCT/EP2008/052847 patent/WO2008113711A1/en not_active Ceased
- 2008-03-18 CL CL2008000785A patent/CL2008000785A1/es unknown
- 2008-03-19 TW TW097109660A patent/TWI363629B/zh not_active IP Right Cessation
- 2008-03-19 US US12/051,000 patent/US7517873B2/en not_active Expired - Fee Related
- 2008-03-19 AR ARP080101142A patent/AR065794A1/es unknown
- 2008-03-19 PE PE2011001933A patent/PE20120495A1/es not_active Application Discontinuation
-
2009
- 2009-08-27 IL IL200617A patent/IL200617A/en not_active IP Right Cessation
-
2011
- 2011-11-30 CY CY20111101174T patent/CY1112102T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0809088A2 (pt) | 2014-09-09 |
| EP2139892A1 (en) | 2010-01-06 |
| CL2008000785A1 (es) | 2009-03-27 |
| JP5087640B2 (ja) | 2012-12-05 |
| PE20120495A1 (es) | 2012-05-12 |
| MX2009010034A (es) | 2009-10-12 |
| SI2139892T1 (sl) | 2011-12-30 |
| PL2139892T3 (pl) | 2012-03-30 |
| IL200617A0 (en) | 2010-05-17 |
| CN101636399A (zh) | 2010-01-27 |
| KR20090119913A (ko) | 2009-11-20 |
| TW200843781A (en) | 2008-11-16 |
| TWI363629B (en) | 2012-05-11 |
| AR065794A1 (es) | 2009-07-01 |
| PT2139892E (pt) | 2011-11-21 |
| US20080234255A1 (en) | 2008-09-25 |
| EP2139892B1 (en) | 2011-09-14 |
| KR101157848B1 (ko) | 2012-07-11 |
| HK1139936A1 (en) | 2010-09-30 |
| JP2010521514A (ja) | 2010-06-24 |
| CN101636399B (zh) | 2012-04-18 |
| AU2008228303A1 (en) | 2008-09-25 |
| CN102746175A (zh) | 2012-10-24 |
| WO2008113711A1 (en) | 2008-09-25 |
| HRP20110807T1 (hr) | 2011-12-31 |
| CN102746175B (zh) | 2014-01-15 |
| ATE524472T1 (de) | 2011-09-15 |
| IL200617A (en) | 2014-02-27 |
| ES2371832T3 (es) | 2012-01-10 |
| CA2680757A1 (en) | 2008-09-25 |
| US7517873B2 (en) | 2009-04-14 |
| AU2008228303B2 (en) | 2012-04-19 |
| DK2139892T3 (da) | 2011-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
| CY1119218T1 (el) | Αναστολεις διυδροπυριδοφθαλαζινονης της πολυμερασης της πολυαδενοσφωσφορικης ριβοζης (parp) | |
| EA200900945A1 (ru) | Новый способ синтеза агомелатина | |
| DK2364308T3 (da) | Pyrazinforbindelser som inhibitorer af Phosphodiesterase 10 | |
| CY1113131T1 (el) | Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1 | |
| CY1113102T1 (el) | Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων | |
| MX2009003834A (es) | Derivados de pirrolidina como inhibidores de iap. | |
| CR20120295A (es) | Triazolopiridinas | |
| CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη | |
| UY29612A1 (es) | Compuestos quimicos ii | |
| CR20110028A (es) | Derivados de pirimidina como inhibidores de cinasa | |
| CY1112705T1 (el) | Συντηγμενες κυκλικες ενωσεις | |
| MA32938B1 (fr) | Composes organiques | |
| CY1112595T1 (el) | Αμιδοφαινοξυινδαζολια χρησιμα ως αναστολεις του c-met | |
| CR20110467A (es) | Derivados de benzofuranilo como inhibidores de la glucoquinasa | |
| CY1110010T1 (el) | Πυριδιναμινοσουλφονυλ υποκατεστημενα βενζαμιδια ως αναστολεις κυτοχρωματος ρ450 3α4 (cyp3a4) | |
| DK1761520T3 (da) | Kinaseinhibitorer | |
| CY1109234T1 (el) | Αναστολεις κινασης | |
| DK2139892T3 (da) | Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer | |
| EA201101675A1 (ru) | Спироэпоксиды как промежуточные продукты синтеза | |
| CY1115094T1 (el) | Νεα μεθοδος για την συνθεση (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στην συνθεση αγομελατινης | |
| EA200900943A1 (ru) | Новый способ синтеза агомелатина | |
| EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
| EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
| EA200900944A1 (ru) | Новый способ получения кристаллической формы v агомелатина |